• 1
    Penovich P, Cereghino J, Debrabandere L, Gauer L. Leveti-racetam: evaluation of efficacy and safety of different dosages in add-on treatment of partial epilepsy. Epilepsia 1998;39(suppl 6):68.
  • 2
    Shorvon S. Levetiracetam in partial epilepsy: results of phase III clinical trials. Eur J Neurol 1998;5(suppl 3):S143.
  • 3
    Ben-Menachem E, Fortpied C, Falter U. Evaluation of the efficacy and tolerability of levetiracetam (LEV) monotherapy in epileptic patients with complex partial seizures. Epilepsia (in press).
  • 4
    Cramer JA, Fisher R, Ben-Menachem E, French J, Mattson RH. New antiepileptic drugs: a comparison of key clinical trials. Epilepsia 1999;40:590600.
  • 5
    Cramer JA. Quality of life and outcome measures for epilepsy clinical trials. Pharmacy World & Sci 1997;19:22730.
  • 6
    Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann BP. Development and cross-cultural translation of a 31-item quality of life questionnaire (QOLIE-31). Epilepsia 1998;39:818.
  • 7
    Devinsky O, Vickrey BG, Cramer JA, Perrine K, Hermann B, Meador K, Hays RD. Development of the Quality of Life in Epilepsy Inventory. Epilepsia 1995;36:10891104.
  • 8
    Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS. Interpreting treatment effects in randomized trials. Br Med J 1998;315:6903.
  • 9
    Wiebe S, Derry PA, McLachlan RS. In search of a minimum clinically important change in epilepsy-specific quality of life instrument. Epilepsia 1997;38(suppl 8):83.
  • 10
    Wiebe S, Rose K, Derry P, McLachlan R. Outcome assessment in epilepsy: comparative responsiveness of quality of life and psychosocial instruments. Epilepsia 1997;38:4308.
  • 11
    Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Controlled Clin Trials 1989;10:40715.
  • 12
    Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimum important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:817.
  • 13
    Redelmeier DA, Guyatt GH, Goldstein RS. Assessing minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996;49:12234.